Skip to content

Insider · CIK 0001310715

Frank Litvack

director

Files at CAPR (CAPRICOR THERAPEUTICS, INC.). First filing -, latest -.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
May 13, 2026CAPR
CAPRICOR THERAPEUTICS, INC.
MOption exercise
Common Stock
+3,937$1.39$5,472133,776May 14, 2026
May 13, 2026CAPR
CAPRICOR THERAPEUTICS, INC.
MOption exercise
Stock Option (Right to Buy)derivative
-3,937$0.00$00May 14, 2026
Jan 5, 2026CAPR
CAPRICOR THERAPEUTICS, INC.
AGrant or award
Stock Option (Right to Buy)derivative
+50,000$0.00$050,000Jan 7, 2026
Mar 3, 2025CAPR
CAPRICOR THERAPEUTICS, INC.
MOption exercise
Common Stock
+25,000$1.39$35k132,382Mar 4, 2025
Mar 3, 2025CAPR
CAPRICOR THERAPEUTICS, INC.
FTax withholding
Common Stock
-2,543$13.67$35k129,839Mar 4, 2025
Mar 3, 2025CAPR
CAPRICOR THERAPEUTICS, INC.
MOption exercise
Stock Option (Right to Buy)derivative
-25,000$0.00$00Mar 4, 2025
Jan 2, 2025CAPR
CAPRICOR THERAPEUTICS, INC.
AGrant or award
Stock Option (Right to Buy)derivative
+50,000$0.00$050,000Jan 6, 2025
Dec 3, 2024CAPR
CAPRICOR THERAPEUTICS, INC.
MOption exercise
Common Stockindirect: Held in Family Trust
+20,391$1.10$22k46,278Dec 4, 2024
Dec 2, 2024CAPR
CAPRICOR THERAPEUTICS, INC.
GGift
Warrants (Right to Buy)derivative
-20,391$0.00$00Dec 4, 2024
Dec 2, 2024CAPR
CAPRICOR THERAPEUTICS, INC.
GGift
Warrants (Right to Buy)derivativeindirect: Held by Family Trust
+20,391$0.00$020,391Dec 4, 2024
Dec 3, 2024CAPR
CAPRICOR THERAPEUTICS, INC.
MOption exercise
Warrants (Right to Buy)derivativeindirect: Held by Family Trust
-20,391$0.00$00Dec 4, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Frank Litvack: insider trades and track record | InsiderTell